Gurugram, India – August 6, 2026 – Medifirm Intelledge Global Pvt. Ltd. today announced the continued expansion of its AI-powered enterprise intelligence platform for the pharmaceutical, biotechnology, healthcare and medical device industries. The platform brings together advanced intelligence, enterprise software and strategic consulting to help organizations make faster, evidence-based decisions across the product lifecycle.

The platform combines Global Drugs (Medicine) Database, Clinical Trial Management (CTMS), Regulatory Vault, Clinical Trial Intelligence, Regulatory Intelligence and Drug Intelligence into a unified ecosystem that supports clinical development, regulatory operations, competitive intelligence and strategic planning.

Designed for life sciences organizations, the platform enables teams to streamline research, monitor global regulatory developments, evaluate competitive landscapes, analyze therapeutic areas and access actionable intelligence through a centralized digital environment. Alongside its technology platform, Medifirm Intelledge Global delivers consulting services in market research, competitive intelligence, clinical development strategy, regulatory strategy, market access, commercial excellence and digital transformation.

"Our vision is to simplify complex decision-making in life sciences by combining AI-powered intelligence with deep industry expertise," said Srishti Sonewal, Founder and Director of Medifirm Intelledge Global. "We are committed to helping pharmaceutical and biotechnology organizations access reliable intelligence, accelerate strategic decisions and navigate an increasingly dynamic global healthcare landscape."

Serving organizations across pharmaceutical, biotechnology, healthcare and medical device sectors, Medifirm Intelledge Global continues to expand its enterprise intelligence capabilities to support research, innovation and informed decision-making across global markets.

For more information, visit www.medifirmintelledgeglobal.com.